BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
Camlin Fine Sciences Ltd.’s Q4 FY22 Ebitda came in 57% below our estimate mainly on account of challenges faced by its European subsidiary in terms of elevated power and fuel costs, owing to the Russia-Ukraine crisis.
Subsidiaries reported a loss of Rs 70 million as Camlin Fine could not pass on Rs 270 million impact from higher power and fuel costs in Italy.
India business’ operational performance improved post ramp-up at Dahej facility. HQ and Catechol, the two diphenols are being produced at Dahej and Italy, wherein production in Italy is sold in the open market. Pass-through mechanism is working well in HQ chain as demand for downstream products is strong.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR